| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.15 | 0.07 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.11 | 0.07 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.07 |